Naloxegol, an Oral Peripherally Acting Opioid Receptor Antagonist, Administered Concurrently with First-Line Systemic Therapy for Advanced Lung Adenocarcinoma (Alliance A221504): A Feasibility and Safety Study.
Saved in:
| Title: | Naloxegol, an Oral Peripherally Acting Opioid Receptor Antagonist, Administered Concurrently with First-Line Systemic Therapy for Advanced Lung Adenocarcinoma (Alliance A221504): A Feasibility and Safety Study. |
|---|---|
| Authors: | Gupta P; VA Long Beach Healthcare System, Long Beach, CA 90822, USA.; Department of Medicine, University of California Irvine, Orange, CA 92868, USA., Gupta K; Department of Medicine, University of California Irvine, Orange, CA 92868, USA., Dockter T; Alliance Statistics and Data Management Center, Mayo Clinic, Rochester, MN 55905, USA., Harlos E; Alliance Statistics and Data Management Center, Mayo Clinic, Rochester, MN 55905, USA., Chow S; Alliance Protocol Operations Office, University of Chicago, Chicago, IL 60606, USA., Subbiah N; Alliance Protocol Operations Office, University of Chicago, Chicago, IL 60606, USA., Ruddy KJ; Department of Medical Oncology, Mayo Clinic Comprehensive Cancer Center, Mayo Clinic, Rochester, MN 55905, USA., Bazhenova L; Department of Medicine, University of California San Diego, San Diego, CA 92093, USA., Terstriep S; Sanford Roger Maris Cancer Center, Fargo, ND 58102, USA., Huang CH; VA Medical Center, Kansas City, MI 64128, USA.; University of Kansas Hospital-Westwood Cancer Center, Kansas City, MI 66205, USA., Kratzke RA; Department of Medicine, University of Minnesota, Minneapolis, MN 55455, USA., Vokes EE; Departments of Medicine and Radiation and Cellular Oncology, University of Chicago, Chicago, IL 60637, USA., Loprinzi CL; Department of Medical Oncology, Mayo Clinic Comprehensive Cancer Center, Mayo Clinic, Rochester, MN 55905, USA. |
| Source: | Cancers [Cancers (Basel)] 2026 Jan 25; Vol. 18 (3). Date of Electronic Publication: 2026 Jan 25. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: MDPI Country of Publication: Switzerland NLM ID: 101526829 Publication Model: Electronic Cited Medium: Print ISSN: 2072-6694 (Print) Linking ISSN: 20726694 NLM ISO Abbreviation: Cancers (Basel) Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2072-6694 |
|---|---|
| DOI: | 10.3390/cancers18030373 |
